Back to BNP PARIBAS FINANCIAL MARKETS BNP PARIBAS FINANCIAL MARKETS

PRQRPRQR
Showing 8 of 21 quarters

Position history for BNP PARIBAS FINANCIAL MARKETSBNP PARIBAS FINANCIAL MARKETS's holdings in PROQR THRAPEUTICS N V

Yes. BNP Paribas Financial Markets holds 275,631 shares of PRQR (Proqr Thrapeutics), worth $512,674, as of its Q2 2026 13F filing. It increased the position by 103,282 shares (+59.9%) from Q1 2026. BNP Paribas Financial Markets has held PRQR since Q2 2022, across 17 quarterly 13F filings.

Current Value

$512,674

Current Shares

275,631

Total Value Change

+$405,656

Total Shares Change

+216,830

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
275,631
+59.9%
$512,6740.0%$1.86
35
2026-Q1
Increased
172,349
+9.7%
$279,2050.0%$1.50
26
2025-Q4
Increased
157,149
+12.6%
$317,4410.0%$2.00
26
2025-Q3
Increased
139,594
+14.9%
$297,3350.0%$2.19
27
2025-Q2
Increased
121,494
+28.4%
$247,8480.0%$2.04
29
2025-Q1
Increased
94,601
+26.6%
$125,8190.0%$1.40
27
2024-Q4
Increased
74,701
+27.0%
$197,9580.0%$2.65
28
2024-Q3
Increased
58,801
+14.2%
$107,0180.0%$1.83
25

Other major holders of PRQR: ADAGE CAPITAL PARTNERS GP, L.L.C., RTW INVESTMENTS, LP, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used